Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Martin Smid

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 1, 2023
Blood transfusion systems in various middle income countries over the worldHans Vrielink, W Martin Smid
Vox Sanguinis|June 18, 2024
Response to comments from the International Patient Organization for Primary Immunodeficiencies on 'Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low- and middle-income countries'Thierry Burnouf, Jay Epstein, Jean-Claude Faber, et al.
Vox Sanguinis|February 9, 2019
False-positive viral marker results in blood donors and their unintended consequences: P. Kiely, V.C. Hoad, E.M. WoodMaud van Zanten, W Martin Smid, Peter van den Burg
Vox Sanguinis|October 24, 2023
Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low- and middle-income countriesThierry Burnouf, Jay Epstein, Jean-Claude Faber, et al.
Vox Sanguinis|May 29, 2020
Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safetyJay Epstein, W Martin Smid, Silvano Wendel, et al.
NPJ Vaccines|December 10, 2020
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infectionsJay Epstein, W Martin Smid, Silvano Wendel, et al.
Transfusion|August 29, 2006
Platelet binding and phagocytosis by macrophagesBahram A Badlou, Ya Ping Wu, W Martin Smid, et al.
Blood Transfusion = Trasfusione Del Sangue|February 14, 2025
Response to comments on inclusion of cryoprecipitate, pathogen-reduced on the WHO model lists of essential medicines for adults and children: a call for actionJay S Epstein, Yuyun Maryuningsih, Jean-Claude Faber, et al.
Blood Transfusion = Trasfusione Del Sangue|February 5, 2024
Inclusion of cryoprecipitate, pathogen-reduced, in the WHO model lists of essential medicines for adults and children: a call for actionJay S Epstein, Yuyun Maryuningsih, Jean-Claude Faber, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 1, 2022
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshopThierry Burnouf, Jay Epstein, Jean-Claude Faber, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 1, 2023
Blood transfusion systems in various middle income countries over the worldHans Vrielink, W Martin Smid
Vox Sanguinis|June 18, 2024
Response to comments from the International Patient Organization for Primary Immunodeficiencies on 'Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low- and middle-income countries'Thierry Burnouf, Jay Epstein, Jean-Claude Faber, et al.
Vox Sanguinis|February 9, 2019
False-positive viral marker results in blood donors and their unintended consequences: P. Kiely, V.C. Hoad, E.M. WoodMaud van Zanten, W Martin Smid, Peter van den Burg
Vox Sanguinis|October 24, 2023
Stepwise options for preparing therapeutic plasma proteins from domestic plasma in low- and middle-income countriesThierry Burnouf, Jay Epstein, Jean-Claude Faber, et al.
Vox Sanguinis|May 29, 2020
Use of COVID-19 convalescent plasma in low- and middle-income countries: a call for ethical principles and the assurance of quality and safetyJay Epstein, W Martin Smid, Silvano Wendel, et al.
NPJ Vaccines|December 10, 2020
Plasma-based COVID-19 treatments in low-and middle-income countries and the risk of transfusion-transmitted infectionsJay Epstein, W Martin Smid, Silvano Wendel, et al.
Transfusion|August 29, 2006
Platelet binding and phagocytosis by macrophagesBahram A Badlou, Ya Ping Wu, W Martin Smid, et al.
Blood Transfusion = Trasfusione Del Sangue|February 14, 2025
Response to comments on inclusion of cryoprecipitate, pathogen-reduced on the WHO model lists of essential medicines for adults and children: a call for actionJay S Epstein, Yuyun Maryuningsih, Jean-Claude Faber, et al.
Blood Transfusion = Trasfusione Del Sangue|February 5, 2024
Inclusion of cryoprecipitate, pathogen-reduced, in the WHO model lists of essential medicines for adults and children: a call for actionJay S Epstein, Yuyun Maryuningsih, Jean-Claude Faber, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 1, 2022
Rationale for supporting stepwise access to safe plasma proteins through local production in low- and middle-income countries: A commentary of an international workshopThierry Burnouf, Jay Epstein, Jean-Claude Faber, et al.
Pageof 2